Posts by Staff

Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer

Posted on Feb 7, 2014 | 1 comment

Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer

New Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer Ovarian cancer is one of the deadliest cancers because it’s often detected at a late stage, with higher risk of resistance to frontline chemotherapy drugs such as paclitaxel (commonly sold as Taxol). However, a new preclinical study from the University of Tehran and the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, published in the Asian Pacific Journal of Cancer Prevention showed that Modified Citrus Pectin (MCP) increased the effectiveness of paclitaxel against ovarian cancer cells.

Read More

Instructions for an Elimination Diet

Posted on May 2, 2013 | 5 comments

Instructions for an Elimination Diet

  By following an “Elimination Diet”, you may be able to identify foods that trigger certain symptoms including joint pain, skin rashes, headaches and much more.  Here’s how to get started.        Elimination Phase – First Two Weeks: Before you begin, make a list or chart of all your symptoms, note their frequency, and rate their severity on a scale of 1 to 10. Note any other characteristics or associations with particular food intake, meal, etc. Eliminate the following food groups along with all food items which contain any of these foods. Dairy...

Read More

Modified Citrus Pectin Protects Against Vascular Hardening

Posted on Nov 21, 2012 | 28 comments

Modified Citrus Pectin Protects Against Vascular Hardening

The research on Modified Citrus Pectin (MCP) continues to grow, highlighting its powerful benefits against inflammation and the protein galectin-3 -- a culprit in heart disease, cancer, inflammation and fibrosis. In this powerful new study, published in Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, MCP blocked galectin-3 and reduced the inflammation, blood pressure, fibrosis and aortic wall thickness associated with vascular hardening and cardiovascular disease. Furthermore, MCP out-performed the pharmaceutical drug sprironolactone, safely without toxicity. Click here to read more about the study.

Read More

Powered by ThreeSided Studios